Cidara Therapeutics, Inc. — Director's Dealing 2021

Oct 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-09-30

Reporting Person: Sandison Taylor (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-30	Common Stock	A	150600	—	Acquired	236631	Direct

Footnotes

F1: All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.

F2: Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2021.